Passage Bio, Inc. (PASG) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Passage Bio, Inc. (PASG) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $17.7M, listed on NASDAQ, employing roughly 60 people, carrying a beta of 1.38 to the broader market. Passage Bio, Inc. Led by William Chou, public since 2020-02-28.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for PASG as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →